REGENXBIO Inc (RGNX)
NASDAQ
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 22.22M | 32.65M | 26.51M | 38.02M | 19.14M | 19.98M | 28.91M | 22.21M |
Operating Income | -71.44M | -62.14M | -70.82M | -58.47M | -66.16M | -73.11M | -64.96M | -63.9M |
Pre Tax Income | -76.76M | -68.18M | -75.48M | -59.98M | -66.68M | -72.06M | -61.87M | -63.04M |
Net Income | -76.72M | -68.18M | -75.48M | -59.94M | -66.68M | -72.06M | -61.87M | -62.89M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -71.44M | -62.14M | -70.82M | -58.47M | -66.16M | -73.11M | -64.96M | -63.9M |
EBITDA | -68.85M | -59.5M | -67.27M | -54.36M | -61.98M | -68.67M | -60.59M | -59.57M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.59M | 10.39M | 218.51M | 35.24M | 154.57M | 470.35M | 119.4M | 90.24M |
Operating Income | -65.44M | -75.89M | 88.1M | -149M | -111.26M | 157.74M | -262.88M | -268.13M |
Pre Tax Income | -63.4M | -73.17M | 104.12M | -97.49M | -106.01M | 141.25M | -280.41M | -263.65M |
Net Income | -62.97M | -73.17M | 99.94M | -94.73M | -111.25M | 127.84M | -280.32M | -263.49M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -2.378 | -2.338 | 2.767 | -2.561 | -2.969 | 2.985 | -6.474 | -5.99 |
EBIT | -65.34M | -75.89M | 88.1M | -149M | -111.26M | 157.74M | -262.88M | -268.13M |
EBITDA | -64.9M | -73.2M | 92.08M | -141.85M | -102.85M | 167.31M | -249.98M | -250.81M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.